Sugi Predict

Sugi Predict / Compounds / SCHEMBL2155390

SCHEMBL2155390

SCHEMBL2155390

C[Si](C)(C)C#CC(CS(=O)(=O)N1CCN(c2ccc(F)cc2)CC1)NC(=O)O

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MMP13 P45452 3/20 0.49
▸ MMP14 P50281 3/20 0.49
▸ CYP3A4 P08684 3/20 0.49
▸ TP53 P04637 1/20 0.46
▸ ADAMTS4 O75173 2/20 0.43
▸ KCNH2 Q12809 1/20 0.43
▸ POLB P06746 2/20 0.42
▸ LMNA P02545 2/20 0.42
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ MAPT P10636 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2156349 0.89 MMP13 (0.52) MMP13MMP14CYP3A4TP53ADAMTS4
SCHEMBL2155412 0.85 CYP3A4 (0.48) MMP13MMP14CYP3A4TP53ADAMTS4
SCHEMBL2155383 0.84 TP53 (0.51) MMP13MMP14CYP3A4TP53POLB
SCHEMBL2155491 0.84 TP53 (0.51) MMP13MMP14CYP3A4TP53POLB
SCHEMBL2155492 0.84 TP53 (0.51) MMP13MMP14CYP3A4TP53POLB
SCHEMBL2156665 0.83 CYP3A4 (0.47) MMP13MMP14CYP3A4TP53ADAMTS4
SCHEMBL2154856 0.82 CYP3A4 (0.44) MMP13MMP14CYP3A4TP53ADAMTS4
SCHEMBL2155117 0.82 CYP3A4 (0.46) MMP13MMP14CYP3A4TP53ADAMTS4
SCHEMBL2156043 0.82 TP53 (0.49) MMP13MMP14CYP3A4TP53POLB
SCHEMBL2156218 0.82 CYP3A4 (0.45) MMP13MMP14CYP3A4TP53ADAMTS4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1828160-B1 SULFONYL AMINO CYCLIC DERIVATIVES AND USE THEREOF AS MMP INHIBITORS MERCK SERONO SA (CH) 2011-12-14 — — EP claimed
US-7973039-B2 3-(1,3-benzodioxol-5-yl)-1-({[4-(4-fluorophenyl)-1-piperazinyl]sulfonyl}methyl)-2-propynyl(hydroxy)formamide; analgesics, anticarcinogenic agents, antiarthritic agents; matrix metalloproteinase inhhibitors MERCK SERONO SA (CH) 2011-07-05 — — US claimed
EP-1828160-B1 SULFONYL AMINO CYCLIC DERIVATIVES AND USE THEREOF AS MMP INHIBITORS MERCK SERONO SA (CH) 2011-12-14 — — EP disclosed
US-7973039-B2 3-(1,3-benzodioxol-5-yl)-1-({[4-(4-fluorophenyl)-1-piperazinyl]sulfonyl}methyl)-2-propynyl(hydroxy)formamide; analgesics, anticarcinogenic agents, antiarthritic agents; matrix metalloproteinase inhhibitors MERCK SERONO SA (CH) 2011-07-05 — — US disclosed
US-20080194520-A1 Sulfonyl Amino Cyclic Derivatives and Use Thereof MERCK SERONO SA (CH) 2008-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194520-A1 Sulfonyl Amino Cyclic Derivatives and Use Thereof GLS2, SRM, GLS MMP13 2288/4885MMP14 2295/4885CYP3A4 1396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.